Product Information
QC SINUS SEVERE 325-200-5 MG is a generic product labeled by Chain Drug Marketing Association, priced at $0.1047 per EA under NDC 83324011524. Its NADAC has been published 90 times since Dec 4, 2024.
QC SINUS SEVERE 325-200-5 MG
ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 200; 5 mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324011524
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/6/2024
Pharmacological Classes
Price Statistics
The NADAC for QC SINUS SEVERE 325-200-5 MG has been published 90 times since Dec 4, 2024, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1047 per EA |
|---|---|
| All-time high | $0.1176 (Jul 16, 2025) |
| All-time low | $0.1047 (Aug 19, 2026) |
| 52-week high | $0.1167 |
| 52-week low | $0.1047 |
| Median price | $0.1140 |
| Average price | $0.1136 |
| Largest weekly change | -3.9% (Jun 17, 2026) |
| Weeks tracked | 90 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QC SINUS SEVERE 325-200-5 MG?
The current National Average Drug Acquisition Cost (NADAC) for QC SINUS SEVERE 325-200-5 MG, manufactured by Chain Drug Marketing Association, is $0.1047 per EA (NDC 83324011524), effective Aug 19, 2026.
How has the price of QC SINUS SEVERE 325-200-5 MG changed over time?
Over the history we have for it, the NADAC for QC SINUS SEVERE 325-200-5 MG has declined 8.6%. It has been tracked across 90 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC SINUS SEVERE 325-200-5 MG?
Since Dec 4, 2024, the NADAC for QC SINUS SEVERE 325-200-5 MG has ranged from a low of $0.1047 (Aug 19, 2026) to a high of $0.1176 (Jul 16, 2025), with a median of $0.1140 per EA.
Are there cheaper alternatives to QC SINUS SEVERE 325-200-5 MG?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC SINUS SEVERE 325-200-5 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures QC SINUS SEVERE 325-200-5 MG?
QC SINUS SEVERE 325-200-5 MG (NDC 83324011524) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.